Literature DB >> 31237446

LncRNA MCM3AP-AS1 Regulates Epidermal Growth Factor Receptor and Autophagy to Promote Hepatocellular Carcinoma Metastasis by Interacting with miR-455.

Hai Zhang1, Cheng Luo1, Guoxing Zhang1.   

Abstract

Hepatocellular carcinoma (HCC) has been reported to be one of the major tumors in the world. There is a study indicating that MCM3AP-AS1 is an oncogenic factor in HCC; however, the mechanism by which MCM3AP-AS1 regulates HCC remains not fully understood. Reverse Transcription-quantitative PCR and Western blot approaches were used to detect mRNA and protein levels of various genes. To examine invasion of HCC cells and lymphatic vessel formation of human dermal lymphatic endothelial cells (HDLECs), we employed transwell invasion assay and lymphatic vessel assay. Bioinformatic analysis and luciferase reporter assay were used to establish direct interactions between MCM3AP-AS1 and miR-455. Besides, The Cancer Genome Atlas analyses of HCCs were performed to determine the association of MCM3AP-AS1 and epidermal growth factor receptor (EGFR) with overall survival. MCM3AP-AS1 knockdown impaired invasion of HCC cells and lymphatic vessel formation of HDLECs. MCM3AP-AS1 directly interacted with miR-455. Furthermore, miR-455 inhibitor-transfected HepG2 cells enhanced the invasion and lymphatic vessel formation abilities. The rescue experiments indicated that EGFR was critical for MCM3AP-AS1- and miR-455-regulated invasion and lymphatic vessel formation. More interestingly, autophagy-related genes (Beclin1, LC3 II/I, and ATG7) were abnormally regulated in miR-455 mimic or inhibitor HepG2 cells. miR-455 mimic inhibited cell invasion and lymphatic vessel formation, which was evidently abrogated by ATG7 overexpression. Finally, we analyzed The Cancer Genome Atlas data sets to test the upregulated expression levels of MCM3AP-AS1 and EGFR. In addition, the results showed that low levels of both genes facilitate survival of HCC patients. In this study, we reveal a novel mechanism underlying MCM3AP-AS1-induced HCC metastasis by regulating miR-455. The conclusions provide more insights into understanding mechanism underlying HCC and help development of therapeutical approaches for treating HCC.

Entities:  

Keywords:  EGFR; MCM3AP-AS1; autophagy; hepatocellular carcinoma; metastasis; miR-455

Mesh:

Substances:

Year:  2019        PMID: 31237446     DOI: 10.1089/dna.2019.4770

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  16 in total

Review 1.  The role of LncRNA MCM3AP-AS1 in human cancer.

Authors:  Shirin Azizidoost; Farhoodeh Ghaedrahmati; Mohadeseh Sheykhi-Sabzehpoush; Shahab Uddin; Mehri Ghafourian; Abdolah Mousavi Salehi; Mona Keivan; Maryam Cheraghzadeh; Zahra Nazeri; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Clin Transl Oncol       Date:  2022-08-24       Impact factor: 3.340

Review 2.  Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance.

Authors:  Rana Shafabakhsh; Farzaneh Arianfar; Massoud Vosough; Hamid Reza Mirzaei; Maryam Mahjoubin-Tehran; Hashem Khanbabaei; Hamed Kowsari; Layla Shojaie; Maryam Ebadi Fard Azar; Michael R Hamblin; Hamed Mirzaei
Journal:  Cancer Gene Ther       Date:  2021-01-11       Impact factor: 5.987

3.  Pro-Angiogenic and Pro-Inflammatory Regulation by lncRNA MCM3AP-AS1-Mediated Upregulation of DPP4 in Clear Cell Renal Cell Carcinoma.

Authors:  Ling Qiu; Yan Ma; Yanming Yang; Xiaojun Ren; Dongzhou Wang; Xiaojing Jia
Journal:  Front Oncol       Date:  2020-06-23       Impact factor: 6.244

4.  MiR-34a Inhibits Cell Proliferation and Induces Apoptosis in Human Nasopharyngeal Carcinoma by Targeting lncRNA MCM3AP-AS1.

Authors:  Piyun Sun; Yuchen Feng; Hui Guo; Rong Li; Peng Yu; Xingguang Zhou; Zhige Pan; Yanyan Liang; Bihan Yu; Yanyi Zheng; Yu Shi; Lingbo Wen; Minmei Wei; Yanhua Chen
Journal:  Cancer Manag Res       Date:  2020-06-22       Impact factor: 3.989

5.  Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma.

Authors:  Yuanbin Jiang; Xin Gou; Zongjie Wei; Jianyu Tan; Haitao Yu; Xiang Zhou; Xinyuan Li
Journal:  Cancer Cell Int       Date:  2020-05-13       Impact factor: 5.722

6.  Long non‑coding RNA MCM3AP‑AS1 drives ovarian cancer progression via the microRNA‑143‑3p/TAK1 axis.

Authors:  Jihong Wen; Shumei Han; Man Cui; Yanli Wang
Journal:  Oncol Rep       Date:  2020-07-17       Impact factor: 3.906

7.  MCM3AP-AS1 promotes cisplatin resistance in gastric cancer cells via the miR-138/FOXC1 axis.

Authors:  Han Sun; Ping Wu; Bao Zhang; Xia Wu; Weixu Chen
Journal:  Oncol Lett       Date:  2021-01-18       Impact factor: 2.967

8.  Linc00426 accelerates lung adenocarcinoma progression by regulating miR-455-5p as a molecular sponge.

Authors:  Hongli Li; Qingjie Mu; Guoxin Zhang; Zhixin Shen; Yuanyuan Zhang; Jun Bai; Liping Zhang; Dandan Zhou; Quan Zheng; Lihong Shi; Wenxia Su; Chonggao Yin; Baogang Zhang
Journal:  Cell Death Dis       Date:  2020-12-11       Impact factor: 8.469

9.  Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma.

Authors:  Chengyun Li; Wenwen Zhang; Hanteng Yang; Jilian Xiang; Xinghua Wang; Junling Wang
Journal:  PeerJ       Date:  2020-03-11       Impact factor: 2.984

10.  Long non-coding RNA MCM3AP-AS1 promotes growth and migration through modulating FOXK1 by sponging miR-138-5p in pancreatic cancer.

Authors:  Ming Yang; Shijuan Sun; Yao Guo; Junjie Qin; Guangming Liu
Journal:  Mol Med       Date:  2019-12-12       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.